In our study, KIF18A inhibition stimulated pro-inflammatory type I IFN signaling activation in CIN+ colorectal tumors, suggesting that KIF18A inhibition changed CIN+ tumors from “immune cold” to “immune hot”. The gene discussed is KIF18A; the disease is colorectal neoplasm.